GlassScriptPhysician profile
Eric C Anderson
NPI 1356507149
$13,469.46
in general payments reported to CMS, 2019-2025
34 companies · $5,516 in 2025
The $5,516 reported for 2025 was more than what 96% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,675 · 2020: $288 · 2021: $468 · 2022: $1,099 · 2023: $722 · 2024: $1,702 · 2025: $5,516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,600 · Food and Beverage: $2,340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,600.00 |
| Food and Beverage | $2,340.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Solutions INC | $6,424.20 | 2024-2025 | |
| Organogenesis INC. | $1,777.90 | 2019-2024 | Puraply Wound Matrix, Puraply |
| Osteomed LLC | $1,500.00 | 2019 | |
| Smith+Nephew, INC. | $1,092.50 | 2019-2025 | Grafix Pl, Collagenase Santyl, Stravix Mesh |
| Inari Medical, INC. | $426.76 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bsn Medical INC | $265.13 | 2023 | |
| Paratek Pharmaceuticals, INC. | $230.29 | 2020-2024 | Nuzyra |
| Ets Wound Care LLC | $216.49 | 2024-2025 | Mirragen Advanced Wound Matrix |
| Paragon 28, INC. | $158.58 | 2019-2022 | |
| Nevro Corp. | $154.87 | 2022-2023 | Senza |
| Stryker Corporation | $142.16 | 2019 | |
| Medtronic Vascular, INC. | $141.98 | 2019 | |
| Kci USA, INC. | $136.79 | 2019-2021 | |
| Convatec INC. | $119.82 | 2020-2022 | |
| Kowa Pharmaceuticals America, INC. | $74.66 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $69.76 | 2021 | |
| Melinta Therapeutics, LLC | $65.01 | 2019-2023 | Kimyrsa |
| Grt US Holding, INC. | $53.51 | 2022 | |
| Alfasigma USA, INC. | $49.86 | 2020 | |
| Celularity INC. | $44.07 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $40.95 | 2021 | |
| Trice Medical, INC. | $39.06 | 2021 | |
| Merck Sharp & Dohme LLC | $31.14 | 2019 | |
| Ossio INC | $29.72 | 2021 | |
| Nabriva Therapeutics, Plc | $28.57 | 2022 | |
| Depuy Synthes Sales INC. | $23.87 | 2021 | |
| Misonix INC | $21.78 | 2021 | |
| Baudax Bio INC. | $19.17 | 2022 | |
| Reprise Biomedical, INC. | $17.50 | 2021 | |
| Cosa Medical, LLC | $15.65 | 2025 | |
| Bioventus LLC | $15.56 | 2022 | |
| Arthrosurface Incorporated | $14.84 | 2019 | |
| Orthofix Medical, INC. | $14.68 | 2019 | |
| Acell, INC. | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.